Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults

This study was a phase I double-blind, randomized, placebo-controlled trial to evaluate the safety and immunogenicity of a Serbian-produced seasonal trivalent split, inactivated influenza vaccine in healthy adults. The vaccine was manufactured in eggs by the Torlak Institute of Virology, Vaccines an...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Human Vaccines & Immunotherapeutics
المؤلفون الرئيسيون:	Goran Stevanovic, Lidija Lavadinovic, Svetlana Filipovic Vignjevic, Renée Holt, Katarina Ilic, Francesco Berlanda Scorza, Erin Sparrow, Vera Stoiljkovic, Guido Torelli, Tamra Madenwald, Muriel Socquet, Aleksandra Barac, Yordanka Ilieva-Borisova, Mijomir Pelemis, Jorge Flores
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Taylor & Francis Group 2018-03-01
الموضوعات:	seasonal influenza vaccine trivalent inactivated split clinical trial serbia torlak
الوصول للمادة أونلاين:	http://dx.doi.org/10.1080/21645515.2017.1415683